Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

202.52
BATS BZX Real-Time Price
As of 12:51pm ET
 -1.03 / -0.51%
Today’s Change
150.06
Today|||52-Week Range
208.88
+9.45%
Year-to-Date

Today’s Trading

Previous close203.55
Today’s open204.44
Day’s range202.30 - 205.29
Volume638,583
Average volume (3 months)2,237,724
Market cap$46.0B
Dividend yield--
Data as of 12:36pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+156.69%
Earnings growth (this year)-4.33%
Earnings growth (next 5 years)+19.69%
Revenue growth (last year)+46.49%
P/E ratio69.3
Price/Sales16.84
Price/Book12.27

Competitors

 Today’s
change
Today’s
% change
SHPGShire+2.82+1.07%
VRTXVertex Pharmaceutica...-0.98-0.76%
PRGOPerrigo Company PLC+0.83+0.43%
MYLMylan NV+0.45+0.80%
Data as of 12:50pm ET, 07/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$1.37
Annual revenue (last year)$2.2B
Annual profit (last year)$656.9M
Net profit margin29.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David L. Hallal
Chief Financial Officer &
Executive Vice President
Vikas Sinha
Corporate headquarters
Cheshire, Connecticut

Forecasts

Partner Financial Offers